SLC7A1 and Parkinson disease: In conclusion, ATP maintenance by “ATP regulators”, i.e., KUSs and esculetin (or ERR agonists), showed significant efficacies for neuroprotection in the MPTP- and rotenone-induced Parkinson's disease model mice.